巨噬细胞NFATc3通过上调miR-204抑制泡沫细胞形成与动脉粥样硬化
本研究在AAV-mutant PCSK9诱导的小鼠动脉粥样硬化模型中,通过巨噬细胞特异性NFATc3敲除与转基因小鼠,结合人类斑块样本,发现NFATc3表达在人和小鼠动脉粥样硬化病变巨噬细胞中降低,且患者外周血单个核细胞NFATc3水平与斑块不稳定性负相关。机制上NFATc3转录上调miR-204,经miR-204-5p抑制SR-A、miR-204-3p抑制CD36转录,减少脂质摄取从而抑制泡沫细胞形成和动脉粥样硬化。
要点
- 巨噬细胞NFATc3是动脉粥样硬化的负调控因子,其缺失促进斑块形成。
- NFATc3通过上调miR-204抑制SR-A和CD36介导的脂质摄取。
- 恢复miR-204可逆转NFATc3敲除小鼠的促动脉粥样硬化表型。
核心结论
- 巨噬细胞NFATc3通过上调miR-204降低SR-A和CD36水平,从而防止泡沫细胞形成和动脉粥样硬化,提示NFATc3/miR-204轴可能是抗动脉粥样硬化的潜在治疗靶点。
研究设计与样本
- 研究采用巨噬细胞特异性NFATc3敲除小鼠和巨噬细胞特异性NFATc3转基因小鼠,在AAV-mutant PCSK9诱导的动脉粥样硬化小鼠模型中评估NFATc3对动脉粥样硬化的影响。
- 研究检测了人和小鼠动脉粥样硬化病变巨噬细胞中NFATc3的表达,并分析了动脉粥样硬化患者外周血单个核细胞NFATc3水平与斑块不稳定性的关联。
主要发现
- 人和小鼠动脉粥样硬化病变巨噬细胞中NFATc3表达降低,动脉粥样硬化患者外周血单个核细胞NFATc3水平与斑块不稳定性呈负相关。
- 巨噬细胞特异性NFATc3敲除小鼠促进动脉粥样硬化斑块形成,而巨噬细胞特异性NFATc3转基因小鼠表现相反表型。
- 巨噬细胞NFATc3缺失通过增强SR-A和CD36介导的脂质摄取促进泡沫细胞形成。
- NFATc3直接靶向并转录上调miR-204水平;成熟miR-204-5p通过经典调控抑制SR-A表达,而miR-204-3p定位于细胞核并抑制CD36转录。
- 恢复miR-204可消除巨噬细胞特异性NFATc3敲除小鼠的促动脉粥样硬化表型,阻断miR-204功能则逆转NFATc3在巨噬细胞中的有益效应。
临床怎么用
- 巨噬细胞NFATc3/miR-204轴可能作为动脉粥样硬化防治的潜在干预靶点,值得进一步转化研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Our previous study demonstrated that Ca2+ influx through the Orai1 store-operated Ca2+ channel in macrophages contributes to foam cell formation and atherosclerosis via the calcineurin-ASK1 pathway, not the classical calcineurin-nuclear factor of activated T-cell (NFAT) pathway. Moreover, up-regulation of NFATc3 in macrophages inhibits foam cell formation, suggesting that macrophage NFATc3 is a negative regulator of atherogenesis. Hence, this study investigated the precise role of macrophage NFATc3 in atherogenesis. METHODS AND RESULTS: Macrophage-specific NFATc3 knockout mice were generated to determine the effect of NFATc3 on atherosclerosis in a mouse model of adeno-associated virus-mutant PCSK9-induced atherosclerosis. NFATc3 expression was decreased in macrophages within human and mouse atherosclerotic lesions. Moreover, NFATc3 levels in peripheral blood mononuclear cells from atherosclerotic patients were negatively associated with plaque instability. Furthermore, macrophage-specific ablation of NFATc3 in mice led to the atherosclerotic plaque formation, whereas macrophage-specific NFATc3 transgenic mice exhibited the opposite phenotype. NFATc3 deficiency in macrophages promoted foam cell formation by potentiating SR-A- and CD36-meditated lipid uptake. NFATc3 directly targeted and transcriptionally up-regulated miR-204 levels. Mature miR-204-5p suppressed SR-A expression via canonical regulation. Unexpectedly, miR-204-3p localized in the nucleus and inhibited CD36 transcription. Restoration of miR-204 abolished the proatherogenic phenotype observed in the macrophage-specific NFATc3 knockout mice, and blockade of miR-204 function reversed the beneficial effects of NFATc3 in macrophages. CONCLUSION: Macrophage NFATc3 up-regulates miR-204 to reduce SR-A and CD36 levels, thereby preventing foam cell formation and atherosclerosis, indicating that the NFATc3/miR-204 axis may be a potential therapeutic target against atherosclerosis.
引用
- Liu X, Guo JW, Lin XC, et al. Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanisms. Eur Heart J. 2021. PMID: 34570211. doi:10.1093/eurheartj/ehab660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。